Drug shortage: Dextrose Monohydrate 50% Injection (DEXTROSE MONOHYDRATE, DEXTROSE)
FDA lists 4 presentations as Current. Availability: Unavailable (1), Limited Availability (2). Reason: Demand increase for the drug; Other. Companies: Amphastar Pharmaceuticals, Inc., Hospira, Inc., a Pfizer Company.
- Published by source
- 2022-01-13
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Amphastar Pharmaceuticals, Inc.
- Products
- Dextrose Monohydrate 50% Injection DEXTROSE MONOHYDRATE DEXTROSE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Next Delivery: October 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
- Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2022-01-13
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #968 | new | 2026-10-22 | 23201355dcc3…707e5c | a2435a858b18…131519 |
Chain head: #1076 8ad5adc30b9b…88ce20